Acadia Healthcare (NASDAQ:ACHC) Updates Q1 2026 Earnings Guidance

Acadia Healthcare (NASDAQ:ACHC) issued an update on its first quarter 2026 earnings guidance on Thursday morning. The company provided earnings per share guidance of 0.250-0.300 for the period, compared to the consensus earnings per share estimate of 0.270. The company issued revenue guidance of $820.0 million-$830.0 million, compared to the consensus revenue estimate of $823.7 million. Acadia Healthcare also updated its FY 2026 guidance to 1.300-1.550 EPS.

Acadia Healthcare Trading Down 3.1%

ACHC traded down $0.85 on Friday, reaching $26.49. 461,270 shares of the company’s stock were exchanged, compared to its average volume of 3,497,344. The company has a debt-to-equity ratio of 1.27, a quick ratio of 1.55 and a current ratio of 1.55. Acadia Healthcare has a twelve month low of $11.43 and a twelve month high of $28.48. The company’s 50 day moving average is $23.36 and its 200-day moving average is $19.14. The company has a market cap of $2.44 billion, a price-to-earnings ratio of -2.17, a PEG ratio of 9.46 and a beta of 0.71.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings data on Wednesday, February 25th. The company reported $0.07 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.03 by $0.04. Acadia Healthcare had a negative net margin of 33.29% and a positive return on equity of 6.53%. The company had revenue of $821.46 million during the quarter, compared to the consensus estimate of $800.10 million. During the same quarter last year, the company earned $0.64 earnings per share. Acadia Healthcare’s revenue for the quarter was up 6.1% on a year-over-year basis. Acadia Healthcare has set its FY 2026 guidance at 1.300-1.550 EPS and its Q1 2026 guidance at 0.250-0.300 EPS. Equities analysts predict that Acadia Healthcare will post 1.48 earnings per share for the current year.

Analyst Ratings Changes

Several analysts have issued reports on the stock. Guggenheim lowered their price objective on shares of Acadia Healthcare from $27.00 to $22.00 and set a “buy” rating for the company in a research report on Monday, February 23rd. TD Cowen increased their price objective on shares of Acadia Healthcare from $22.00 to $24.00 and gave the company a “buy” rating in a research report on Thursday, February 26th. Jefferies Financial Group reaffirmed a “hold” rating and issued a $24.50 price objective on shares of Acadia Healthcare in a research report on Monday. Raymond James Financial reaffirmed an “outperform” rating and issued a $25.00 price objective on shares of Acadia Healthcare in a research report on Thursday, February 26th. Finally, UBS Group increased their target price on Acadia Healthcare from $27.00 to $31.00 and gave the company a “buy” rating in a research note on Friday, April 17th. Seven equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat.com, Acadia Healthcare currently has an average rating of “Hold” and an average price target of $22.19.

Institutional Investors Weigh In On Acadia Healthcare

Several institutional investors and hedge funds have recently made changes to their positions in ACHC. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new stake in shares of Acadia Healthcare during the 1st quarter valued at approximately $1,600,000. Goldman Sachs Group Inc. grew its stake in Acadia Healthcare by 21.1% during the 1st quarter. Goldman Sachs Group Inc. now owns 698,225 shares of the company’s stock worth $21,170,000 after buying an additional 121,444 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in Acadia Healthcare by 8.7% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 340,916 shares of the company’s stock worth $10,337,000 after buying an additional 27,207 shares during the last quarter. American Century Companies Inc. grew its stake in Acadia Healthcare by 531.5% during the 2nd quarter. American Century Companies Inc. now owns 105,739 shares of the company’s stock worth $2,399,000 after buying an additional 88,995 shares during the last quarter. Finally, Prudential Financial Inc. grew its position in Acadia Healthcare by 21.9% in the 2nd quarter. Prudential Financial Inc. now owns 9,903 shares of the company’s stock valued at $225,000 after buying an additional 1,780 shares in the last quarter.

About Acadia Healthcare

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.